Commentary

Evaluating the impact of FDA’s pregnancy and lactation labeling rule


 

Dr. Chambers is a professor of pediatrics and director of clinical research at Rady Children’s Hospital, and associate director of the Clinical and Translational Research Institute at the University of California, San Diego. She is director of MotherToBaby California, a past president of the Organization of Teratology Information Specialists, and past president of the Teratology Society. She has no relevant financial disclosures. To comment, e-mail her at obnews@frontlinemedcom.com.

Pages

Recommended Reading

VIDEO: Kisspeptin outperforms HCG for early miscarriage prediction
MDedge Endocrinology
Donated IVF eggs linked to gestational hypertension
MDedge Endocrinology
Gestational diabetes and the Barker Hypothesis
MDedge Endocrinology
Gestational diabetes may increase child’s risk of glucose intolerance
MDedge Endocrinology
Eating fried food before pregnancy may increase risk of gestational diabetes
MDedge Endocrinology
Maternal weight before pregnancy linked to children’s cognition
MDedge Endocrinology
Retinopathy screening during gestational diabetes may be lacking
MDedge Endocrinology
Timing of lifestyle interventions for obesity
MDedge Endocrinology
Topiramate
MDedge Endocrinology
FDA issues new pregnancy/lactation drug label standards
MDedge Endocrinology

Related Articles